Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Glioma × Lomustine × Clear all

Phase

Status

Completed 7 Unknown 2 Active not recruiting 2 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1

Interventions

Temozolomide 3 vorasidenib 1 trametinib 1 tovorafenib 1 posaconazole 1 perillyl alcohol 1 pembrolizumab 1 niraparib 1 gallium maltolate 1 dabrafenib 1 contrast agent BR1 1 Standard of Care 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Physical Therapy Modalities 1 Nivolumab 1 Microscopy 1 Mental Status and Dementia Tests 1 Lomustine 1 Ketoconazole 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Electrocorticography 1 Electric Stimulation 1 Cyclophosphamide 1 Craniotomy 1 Blood Specimen Collection 1 Biopsy 1 Bevacizumab 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07120984 2025-08-13

IMAGLIO

Philogen S.p.A.

Phase 2 Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡